---
title: "Immutep tumbles 8% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/306302977.md"
description: "Immutep fell 8.40% to US$3.132. Down 65.57% over six months and down 94.37% YTD."
datetime: "2026-11-20T16:07:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/306302977.md)
  - [en](https://longbridge.com/en/news/306302977.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/306302977.md)
generator: "portal-rs"
---

# Immutep tumbles 8% during regular trading

Immutep (IMMP.US) tumbled more than **8%** during regular trading to **$3.132**.

The stock is down 65.57% over the past six months and down 94.37% year to date. It sits 95.56% below its 52-week high of US$70.59.

The Nasdaq Composite is down 7.44% over the past five sessions and up 0.10% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [IMMP.US](https://longbridge.com/en/quote/IMMP.US.md)

## Related News & Research

- [IMMU: VITAL-CML cleared safety, with key AML and CML readouts due through 2027](https://longbridge.com/en/news/305179446.md)
- [Immutep Reports Encouraging Survival Data From Phase 2 Cancer Trial](https://longbridge.com/en/news/305195688.md)
- [NASDAQ composite is now down on the year](https://longbridge.com/en/news/306307167.md)
- [Anthropic lacks ‘basic moral compass’, say publishers](https://longbridge.com/en/news/306295252.md)
- [Marvell Stock’s (MRVL) Plunge Is My Opportunity to Buy](https://longbridge.com/en/news/306273400.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**